$RCAR·4

RenovaCare, Inc. · Feb 3, 2:58 PM ET

RenovaCare, Inc. 4

4 · RenovaCare, Inc. · Filed Feb 3, 2016

Insider Transaction Report

Form 4
Period: 2016-02-02
Transactions
  • Conversion

    Series B Stock Purchase Warrant

    2016-02-02$0.46/sh2,173,913$1,000,0005,626,087 total(indirect: Kalen Capital Corporation)
    Exercise: $0.46From: 2013-11-29Exp: 2018-11-29Common stock, par value $0.00001 (1,326,087 underlying)
  • Purchase

    Common stock, par value $0.00001

    2016-02-02$0.46/sh+2,173,913$1,000,00044,550,713 total(indirect: Kalen Capital Corporation)
Footnotes (5)
  • [F1]On February 2, 2016, Kalen Capital Corporation exercised a Series B Stock Purchase Warrant for 2,173,913 shares of Issuers common stock at an exercise price of $0.46 per share for payment of $999,999.98.
  • [F2]Does not include derivative securities beneficially owned by Mr. Rayat.
  • [F3]Mr. Rayat is the sole shareholder and sole director of Kalen Capital Corporation.
  • [F4]Represents the number of shares remaining issuable upon exercise of the Series B Stock Purchase Warrant.
  • [F5]Includes (a) a Series B Stock Purchase Warrant to purchase up to 1,326,087 shares of the Issuers common stock at an exercise price of $0.46 per share through November 29, 2018; (b) a Series C Stock Purchase Warrant to purchase up to 3,500,000 shares of the Issuers common stock at an exercise price of $0.49 per share through November 29, 2018; and (c) a Series D Stock Purchase Warrant to purchase up to 800,000 shares of the Issuers common stock at an exercise price of $1.10 per share through June 5, 2020. Each of the foregoing warrants may be exercised on a cashless basis.

Documents

1 file
  • 4
    primary_doc.xmlPrimary

    PRIMARY DOCUMENT